These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 38227209)

  • 21. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids.
    Yao Y; Chen H; Yan L; Wang W; Wang D
    Biomed Pharmacother; 2020 Nov; 131():110669. PubMed ID: 32937246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
    Massey W; Brown JM
    Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gut-targeted therapies for type 2 diabetes mellitus: A review.
    Xu TC; Liu Y; Yu Z; Xu B
    World J Clin Cases; 2024 Jan; 12(1):1-8. PubMed ID: 38292634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
    Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
    mBio; 2018 May; 9(3):. PubMed ID: 29789365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut Microbiota: An Important Player in Type 2 Diabetes Mellitus.
    Zhou Z; Sun B; Yu D; Zhu C
    Front Cell Infect Microbiol; 2022; 12():834485. PubMed ID: 35242721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical potential and mechanistic insights of mulberry (Morus alba L.) leaves in managing type 2 diabetes mellitus: Focusing on gut microbiota, inflammation, and metabolism.
    Tang C; Bao T; Zhang Q; Qi H; Huang Y; Zhang B; Zhao L; Tong X
    J Ethnopharmacol; 2023 Apr; 306():116143. PubMed ID: 36632855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
    Zhu T; Goodarzi MO
    Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition.
    Zou J; Xiang Q; Tan D; Shi L; Liu X; Wu Y; Yu R
    Biomed Pharmacother; 2023 Jan; 157():114002. PubMed ID: 36410120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulating the gut microbiota and SCFAs in the faeces of T2DM rats should be one of antidiabetic mechanisms of mogrosides in the fruits of Siraitia grosvenorii.
    Zhang Y; Peng Y; Zhao L; Zhou G; Li X
    J Ethnopharmacol; 2021 Jun; 274():114033. PubMed ID: 33741440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut microbiota: The key to the treatment of metabolic syndrome in traditional Chinese medicine - a case study of diabetes and nonalcoholic fatty liver disease.
    Bao Y; Han X; Liu D; Tan Z; Deng Y
    Front Immunol; 2022; 13():1072376. PubMed ID: 36618372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Gut Microbiome and Microbial Metabolites in Alleviating Insulin Resistance After Bariatric Surgery.
    Wang M; Li L; Chen Y; Lian G; Wang J; Zhang J; Shan K; Shang L; Tian F; Jing C
    Obes Surg; 2021 Jan; 31(1):327-336. PubMed ID: 32974816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.
    Lee CB; Chae SU; Jo SJ; Jerng UM; Bae SK
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota.
    Zhang HY; Tian JX; Lian FM; Li M; Liu WK; Zhen Z; Liao JQ; Tong XL
    Biomed Pharmacother; 2021 Jan; 133():110857. PubMed ID: 33197760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 Fatty Acids and Their Interaction with the Gut Microbiome in the Prevention and Amelioration of Type-2 Diabetes.
    Kumar M; Pal N; Sharma P; Kumawat M; Sarma DK; Nabi B; Verma V; Tiwari RR; Shubham S; Arjmandi B; Nagpal R
    Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM).
    Tanase DM; Gosav EM; Neculae E; Costea CF; Ciocoiu M; Hurjui LL; Tarniceriu CC; Maranduca MA; Lacatusu CM; Floria M; Serban IL
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33276482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary flaxseed oil rich in omega-3 suppresses severity of type 2 diabetes mellitus via anti-inflammation and modulating gut microbiota in rats.
    Zhu L; Sha L; Li K; Wang Z; Wang T; Li Y; Liu P; Dong X; Dong Y; Zhang X; Wang H
    Lipids Health Dis; 2020 Feb; 19(1):20. PubMed ID: 32028957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The potential mechanism of Liu-Wei-Di-Huang Pills in treatment of type 2 diabetic mellitus: from gut microbiota to short-chain fatty acids metabolism.
    Yi ZY; Chen L; Wang Y; He D; Zhao D; Zhang SH; Yu R; Huang JH
    Acta Diabetol; 2022 Oct; 59(10):1295-1308. PubMed ID: 35857109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Integrated Fecal Microbiome and Metabolomics in T2DM Rats Reveal Antidiabetes Effects from Host-Microbial Metabolic Axis of EtOAc Extract from
    Shao J; Liu Y; Wang H; Luo Y; Chen L
    Oxid Med Cell Longev; 2020; 2020():1805418. PubMed ID: 32566075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted modulation of gut microbiota by traditional Chinese medicine and natural products for liver disease therapy.
    Zhu LR; Li SS; Zheng WQ; Ni WJ; Cai M; Liu HP
    Front Immunol; 2023; 14():1086078. PubMed ID: 36817459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.